ATE352298T1 - Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung - Google Patents

Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung

Info

Publication number
ATE352298T1
ATE352298T1 AT02766531T AT02766531T ATE352298T1 AT E352298 T1 ATE352298 T1 AT E352298T1 AT 02766531 T AT02766531 T AT 02766531T AT 02766531 T AT02766531 T AT 02766531T AT E352298 T1 ATE352298 T1 AT E352298T1
Authority
AT
Austria
Prior art keywords
avermectin compound
treating dermatoses
kit
acne
dermatitis
Prior art date
Application number
AT02766531T
Other languages
English (en)
Inventor
L Dean Parks
Original Assignee
L Dean Parks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L Dean Parks filed Critical L Dean Parks
Application granted granted Critical
Publication of ATE352298T1 publication Critical patent/ATE352298T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT02766531T 2001-10-12 2002-10-03 Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung ATE352298T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/976,915 US6399651B1 (en) 2000-06-29 2001-10-12 Method of treating dermatoses using avermectin compound

Publications (1)

Publication Number Publication Date
ATE352298T1 true ATE352298T1 (de) 2007-02-15

Family

ID=25524622

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02766531T ATE352298T1 (de) 2001-10-12 2002-10-03 Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung

Country Status (9)

Country Link
US (2) US6399651B1 (de)
EP (1) EP1450785B1 (de)
AT (1) ATE352298T1 (de)
CY (1) CY1106528T1 (de)
DE (1) DE60217900T2 (de)
DK (1) DK1450785T3 (de)
ES (1) ES2278046T3 (de)
PT (2) PT1450785E (de)
WO (1) WO2003032976A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
WO2004093886A1 (en) * 2003-04-24 2004-11-04 Galderma S.A. Topical formulation of ivermectin for the treatment of dermatological conditions
GB0316377D0 (en) * 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US7714015B2 (en) * 2003-08-07 2010-05-11 Lil Brat Pharmaceuticals Of Marlette, Mi Method and composition for treating sunburned skin
DE102004009904A1 (de) * 2004-02-26 2005-09-22 Grünenthal GmbH Kit aus einem gegebenenfalls wirkstoffhaltigen Pflaster und einem Hautirritationen verhindernden Mittel
FR2867684B1 (fr) * 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine
DE602005020912D1 (de) * 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme
FR2894823B1 (fr) * 2005-12-20 2008-02-29 Galderma Sa Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
FR2900052B1 (fr) * 2006-04-19 2011-02-18 Galderma Sa Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine
FR2906468B1 (fr) * 2006-09-28 2012-09-21 Galderma Sa Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques
CA2666365C (en) * 2006-10-12 2016-08-09 Topaz Pharmaceuticals Llc Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
US8901163B2 (en) 2007-01-03 2014-12-02 Galderma S.A. Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound
US20080226701A1 (en) * 2007-03-15 2008-09-18 John Deignan Medicated patches
US8541022B2 (en) * 2008-06-02 2013-09-24 Galderma S.A. Method of treating burns using avermectin compound
FR2937972B1 (fr) 2008-11-04 2013-03-29 Galderma Res & Dev Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
WO2012054328A1 (en) 2010-10-20 2012-04-26 Galderma S.A. Method of treating hemorrhoids using macrocyclic lactone compound
EP2629770B1 (de) 2010-10-20 2016-05-25 Galderma S.A. Ivermectin zur behandlung von gehörgangsentzündungen
WO2012106058A2 (en) 2011-01-31 2012-08-09 New Market Pharmaceuticals Animal treatments
CN102599178B (zh) * 2012-02-13 2013-11-27 中国水稻研究所 异丙威和依维菌素复配农药
EP3505159B1 (de) 2012-05-02 2020-11-04 NewMarket Pharmaceuticals LLC Pharmazeutische zusammensetzungen zur direkten systemischen einführung
US9782425B2 (en) 2013-07-08 2017-10-10 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US9233117B2 (en) 2013-07-08 2016-01-12 Galderma S. A. Treatment of inflammatory lesions of rosacea with ivermectin
CN105916511A (zh) 2013-11-29 2016-08-31 盖尔德玛公司 用于治疗和/或预防特应性皮炎的阿维菌素家族或美贝霉素家族的化合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US5439924A (en) * 1991-12-23 1995-08-08 Virbac, Inc. Systemic control of parasites
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5654312A (en) * 1995-06-07 1997-08-05 Andrulis Pharmaceuticals Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US6057372A (en) * 1996-06-11 2000-05-02 Soda Aromatic Co., Ltd. Antibacterial agents and cosmetics and clothing containing the same
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6262031B1 (en) * 1999-03-12 2001-07-17 Merck & Co., Inc. Method for treating pediculosis capitisinfestation
US6133310A (en) * 1999-08-26 2000-10-17 Parks; L. Dean Method of treatment of rosacea
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
US6319945B1 (en) * 2000-06-29 2001-11-20 L. Dean Parks Method of treatment of seborrheic dermatitis
US6399652B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound

Also Published As

Publication number Publication date
US20020156029A1 (en) 2002-10-24
US20020035076A1 (en) 2002-03-21
PT1439832E (pt) 2007-06-05
EP1450785A1 (de) 2004-09-01
DE60217900D1 (de) 2007-03-15
US6399651B1 (en) 2002-06-04
EP1450785A4 (de) 2005-01-05
WO2003032976A1 (en) 2003-04-24
ES2278046T3 (es) 2007-08-01
DE60217900T2 (de) 2007-11-08
EP1450785B1 (de) 2007-01-24
PT1450785E (pt) 2007-04-30
CY1106528T1 (el) 2012-01-25
DK1450785T3 (da) 2007-05-14

Similar Documents

Publication Publication Date Title
DE60217900D1 (de) Verfahren zur behandlung von dermatosen mit einer avermectin-verbindung
DK1071417T3 (da) Anvendelse af cannabidiol som anti-inflammatorisk middel
ES2159309T3 (es) Semillas tratadas.
BRPI0506977A (pt) composto de tetrahidrocarbolina como agentes anticáncer
PT1296959E (pt) Metodos e composicoes que utilizam quinazolinonas
PT1318992E (pt) Derivados do imidazole como inibidores da cinase raf
ATE430589T1 (de) Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
AR020417A1 (es) Fertilizante folial y metodo de empleo.
ES2153337T1 (es) Inhibidores de raf-quinasa.
BRPI0407970B8 (pt) membro radioativo para uso em braquiterapia, e, método para a produção de um membro radioativo para uso em braquiterapia
DK1596880T3 (da) Fremgangsmåder og sammensætninger til undertrykkelse af fibrocytdifferentiering
CY1111263T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει sns-595 και χρησεις αυτης
NO20071426L (no) Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib
BRPI0518776A2 (pt) composiÇço e mÉtodo para o cuidado oral, e, mÉtodos para inibir a inflamaÇço em um tecido oral de um paciente, e para promover a saéde oral em um paciente
NO20030692L (no) Fremgangsmåte til fremstilling av en absorberende hygiensik artikkel som omfatter melkesyredannende bakterier
BRPI0412130A (pt) compostos tetracìclicos como inibidores de c-met
BR0312099A (pt) Uso de toxina bolutìnica, bem como composição farmacêutica
MX9308013A (es) 4-fenil-piridonas y 4-fenil-2-fenil-2-alcoxipiridinas sustituidas, procedimiento para su preparacion y medicamentos que los contienen.
EP1628667A4 (de) Verfahren zur behandlung von erkrankungen mit hsp90-hemmenden mitteln in kombination mit antimitotika
BR0215362A (pt) método para melhorar a aparência estética da pele
ATE421877T1 (de) Verwendung von totarol zur behandlung von pruritus
NO20053649L (no) Kombinasjonsterapi
DK1485059T3 (da) Topisk dapson til behandling af akne
WO2001064251A3 (en) Combination chemotherapy
WO2004043424A8 (en) Method of stimulating hair growth using benzopyrans

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1450785

Country of ref document: EP